Equities

Biohit Oyj

Biohit Oyj

Actions
Health CareMedical Equipment and Services
  • Price (EUR)2.00
  • Today's Change0.04 / 2.04%
  • Shares traded17.61k
  • 1 Year change+17.30%
  • Beta0.6936
Data delayed at least 15 minutes, as of Mar 28 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • BIOBV:HEX price rises above 200-day moving average to 1.94 at 10:00 BST
  • BIOBV:HEX price rises above 200-day moving average to 1.95 at 11:08 BST
  • BIOBV:HEX price moved over +2.60% to 1.97
  • BIOBV:HEX price rises above 50-day moving average to 1.94 at 10:00 BST
  • BIOBV:HEX price rises above 200-day moving average to 1.97 at 10:15 BST
  • BIOBV:HEX price rises above 50-day moving average to 1.95 at 11:08 BST
  • BIOBV:HEX price falls below 50-day moving average to 1.91 at 11:24 BST
  • BIOBV:HEX trading volume exceeds daily average by +24.08%
  • BIOBV:HEX price rises above 15-day moving average to 1.94 at 10:00 BST
  • BIOBV:HEX price rises above 15-day moving average to 1.95 at 11:08 BST

Key statistics

On Thursday, Biohit Oyj (BIOBV:HEX) closed at 2.00, -9.91% below its 52-week high of 2.22, set on Aug 09, 2023.
52-week range
Today
1.63Mar 28 20232.22Aug 09 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open1.97
High2.00
Low1.95
Bid--
Offer--
Previous close1.96
Average volume12.14k
Shares outstanding12.14m
Free float3.41m
P/E (TTM)16.25
Market cap24.28m EUR
EPS (TTM)0.1231
EUR
Data delayed at least 15 minutes, as of Mar 28 2024 17:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.